Effect of Paclitaxel on the beta-actin, Fibronectin, Laminin and Fine Structure in HeLa and L929 Cells.
- Author:
Joo Young KIM
1
;
Yin LIU
;
Hoon Ki SUNG
;
Jeong Hyun PARK
;
In Hwan SONG
;
Eon Gi SUNG
;
Yungchang LEE
Author Information
1. Department of Anatomy, College of Medicine, Yeungnam University, Taegu, Korea.
- Publication Type:Original Article
- Keywords:
beta-Actin;
Fibronectin;
Laminin;
HeLa;
L929;
Paclitaxel
- MeSH:
Actins*;
Cell Proliferation;
Cytoplasm;
Fibronectins*;
Golgi Apparatus;
HeLa Cells;
Heterochromatin;
Humans;
Immunohistochemistry;
Laminin*;
Paclitaxel*
- From:Korean Journal of Anatomy
2001;34(1):1-11
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
The aim of this investigation was to elucidate the changes in the cytoplasmic distribution of beta-actin, fibronectin, and laminin through mainly the morphological changes occurring in HeLa and L929 cancer cell treated with paclitaxel. Whether or not paclitaxel regulates cell proliferation was assessed with MTT assay. Possible influence on the distribution of beta-actin, fibronectin, and laminin in these cells was confirmed with immunocytochemistry and analySIS Auto software program. The changes in cell morphology were observed under inverted and electron microscope. The MTT assay showed that 1 micrometer and 10 micrometer concentrations of paclitaxel inhibited HeLa cell growth approximately by 20% to 80% and L929 cell by 27% to 44% in a dose- and time-dependent manner. The distribution of these proteins was changed from the condensed around nucleus and strong reaction to the weak throughout cytoplasm. The morphological changes indicated that paclitaxel changes the location or number of protein synthesis apparatus: damages of RERs, Golgi complex, and increase of heterochromatin. These data suggest that the growth inhibition and morphological changes of tumor cells induced by paclitaxel might be modulated by the rearrangement and decreased production of beta-actin, fibronectin, and laminin in cytoplasm.
